The effect of vedolizumab (anti-47-integrin) therapy on colonic mucosal gene expression in patients with ulcerative colitis (UC)
Homo sapiens
175 Downloadable Samples
Affymetrix Human Gene 1.0 ST Array (hugene10st)
Submitter Supplied Information
Description
Microarrays were used to investigate the the effect of vedolizumab (VDZ) therapy on colonic mucosal gene expression in UC patients and compared the changes to those observed with infliximab (IFX) therapy.